Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Analyzing genes for changes before and after chemotherapy may help doctors predict
a patient's response to treatment and help plan the most effective treatment.
PURPOSE: This clinical trial is studying how well genetic testing works in predicting
response to paclitaxel in women who have unresected breast cancer.